Surfactant: Overview

Encyclopedia of Respiratory Medicine, Four-Volume Set

Volumn , Issue , 2006, Pages 135-143

  Notter, R H ^a   Chess, P R ^a   Wang, Z ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

ALI; Alveolar stability; Alveolar type II cells; ARDS; Exogenous surfactant; Lung injury; Lung surfactant; RDS; Surface tension; Surfactant deficiency; Surfactant dysfunction; Surfactant replacement

Indexed keywords

EID: 79952315761     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B0-12-370879-6/00376-8     Document Type: Chapter

References (15)

1. Avery M.E., Mead J. Surface properties in relation to atelectasis and hyaline membrane disease. American Journal of Diseases of Children 1959, 97:517-523.
2. Bernard G.R., Artigas A., Brigham K.L., et al. The American-European consensus conference on ARDS. definitions, mechanisms, relevant outcomes, and clinical trial coordination. American Journal of Respiratory and Critical Care Medicine 1994, 149:818-824.
3. Clements J.A. Surface tension of lung extracts. Proceedings of the Society for Experimental Biology and Medicine 1957, 95:170-172.
4. Hall S.B., Venkitaraman A.R., Whitsett J.A., Holm B.A., Notter R.H. Importance of hydrophobic apoproteins as constituents of clinical exogenous surfactants. American Review of Respiratory Disease 1992, 145:24-30.
5. Holm B.A., Wang Z., Notter R.H. Multiple mechanisms of lung surfactant inhibition. Pediatric Research 1999, 46:85-93.
6. Nogee L.M., Garnier G., Dietz H.C., et al. A mutation in the surfactant protein B gene responsible for fatal neonatal respiratory disease in multiple kindreds. Journal of Clinical Investigation 1994, 93:1860-1863.
7. Notter R.H. Lung Surfactants: Basic Science and Clinical Applications 2000, 444. Dekker, New York.
8. Notter RH, Finkelstein JN, and Holm BA (eds.) (2005) Lung Injury: Mechanisms, Pathophysiology, and Therapy, chs 3, 9, 15, 19, p. 847. Boca Raton: Taylor and Francis.
9. Notter R.H., Wang Z. Pulmonary surfactant. physical chemistry, physiology, and replacement. Reviews in Chemical Engineering 1997, 13:1-118.
10. Notter R.H., Wang Z., Egan E.A., Holm B.A. Component-specific surface and physiological activity in bovine-derived lung surfactants. Chemistry and Physics Lipids 2002, 114:21-34.
11. Pattle R.E. Properties, function, and origin of the alveolar lining layer. Nature 1955, 175:1125-1126.
12. Petty T.L., Ashbaugh D.G. The adult respiratory distress syndrome. Clinical features, factors influencing prognosis and principles of management. Chest 1971, 60:233-239.
13. Seeger W.C., Grube C., Günther A., Schmidt R. Surfactant inhibition by plasma proteins. differential sensitivity of various surfactant preparations. European Respiratory Journal 1993, 6:971-977.
14. Wang Z., Schwan A.L., Lairson L.L., et al. Surface activity of a synthetic lung surfactant containing a phospholipase-resistant phosphonolipid. American Journal of Physiology: Lung Cellular and Molecular Physiology 2003, 285:L550-L559.
15. Willson D.F., Thomas N.J., Markovitz B.P., et al. Effect of exogenous surfactant (calfactant) in pediatric acute lung injury. a randomized controlled trial. Journal of the American Medical Association 2005, 293:470-476.